T1	Participants 672 706	mean+/-SD: 3.85+/-1.98 for group 1
T2	Participants 711 734	2.78+/-1.03 for group 2
T3	Participants 782 813	three (15%) patients in group 2
T4	Participants 818 847	two (10%) patients in group 1
T5	Participants 917 971	Ciprofloxacin and rifampicin treatment for brucellosis
T6	Participants 250 321	rifampicin 600 mg/day and doxycycline 200 mg/day for 45 days (group 1),
T7	Participants 329 398	rifampicin 600 mg/day and ciprofloxacin 1 g/day for 30 days (group 2)
T8	Participants 400 446	Forty patients were diagnosed with brucellosis
